Previous 10 | Next 10 |
2023-05-04 22:48:02 ET Bio-Rad Laboratories, Inc. (BIO) Q1 2023 Results Conference Call May 04, 2023 05:00 PM ET Company Participants Ed Chung - Vice President, Investor Relations Norman Schwartz - Chief Executive Officer Ilan Daskal - Executive Vice President &a...
2023-05-04 17:28:10 ET Bio-Rad Labs press release ( NYSE: BIO ): Q1 Non-GAAP EPS of $3.34 misses by $0.14 . Revenue of $676.8M (-3.3% Y/Y) misses by $12.48M . Updated 2023 Financial Outlook Bio-Rad is updating its financial outlook for full-year 2023. The c...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced financial results for the first quarter ended March 31, 2023. First-quarter 2023 net sales were $676.8 million, a decrease of 3.3 percent compared to $70...
2023-04-20 10:14:49 ET Shares of Life Sciences tool makers Thermo Fisher Scientific ( TMO ), Danaher Corporation ( DHR ), Repligen ( RGEN ), and Bio-Rad Laboratories ( BIO ) came under pressure after their EU peer Sartorius ( OTCPK:SARTF ) disappointed with its Q1 2023 e...
2023-04-13 11:12:23 ET Summary Bio-Rad is back on the table as an attractive value proposition once again. The firm is well-positioned to unlock tremendous value for shareholders looking ahead, in my estimation. Profitability is a standout, and the Sartorius equity position is...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, will report its financial results for the first quarter of 2023 on Thursday, May 4, 2023, following the close of the market. Management will discuss these results in a confe...
2023-03-21 09:00:58 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips This year the National Institutes of Health is set to request its biggest budget yet for 2024, on the heels of its previous biggest budget in 2023. As the COVID-19 pandemic fades from view, l...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Nearly three months after the launch of OpenAI’s ChatGPT, investors remain hyper-focused on artificial intelligence ( AI ). There’s plenty of reason to be. Major companies are working around the clock to perfe...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced that the company’s management will participate in a fireside chat event during Citi’s 2023 Healthcare Services, MedTech, Tools & HCIT Confe...
Bio-Rad Laboratories, Inc. (BIO) Q4 2022 Earnings Conference Call February 16, 2023 5:00 PM ET Company Participants Edward Chung - Vice President, Investor Relations Ilan Daskal - Chief Financial Officer Andrew Last - Chief Operating Officer Norman Schwartz - Presi...
News, Short Squeeze, Breakout and More Instantly...
Bio-Rad Laboratories Inc. Class A Company Name:
BIO Stock Symbol:
NYSE Market:
Bio-Rad Laboratories Inc. Class A Website:
2024-06-20 03:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-10 04:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Anette Engelhardt will join the company as its new Executive Vice President and President of the Clinical Diagnostics Group, effective June 10, 2024. ...